Perspective Therapeutics's market cap is currently $252.49M. The company's EPS TTM is $-0.3; its P/E ratio is ―; Perspective Therapeutics is scheduled to report earnings on August 13, 2025, and the estimated EPS forecast is $-0.32. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24
Dec 23
Dec 22
Jun 22
Jun 21
Currency in USD
Perspective Therapeutics Earnings and Revenue History
